Cyclophosphamide, cytosine arabinoside and methotrexate versus cytosine arabinoside and thioguanine for acute non-lymphocytic leukemia in adults

Treatment of adult acute leukemia with arabinosylcytosine and thioguanine

1969 • 211 citations

The use of tumor growth kinetics in planning "curative" chemotherapy of advanced solid tumors.

1969 • 149 citations

Acute myelocytic leukemia in adults

1972 • 137 citations

Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient

1977 • 101 citations

Intensive chemotherapy in children with acute lymphoblastic leukemia (L‐2 protocol)

1974 • 101 citations

Acute lymphocytic leukemia in childhood.

1974 • 99 citations

Comparative study of cytosine arabinoside therapy alone and combined with thioguanine, mercaptopurine, or daunorubicin in acute myelocytic leukemia

1975 • 85 citations

Intensive chemotherapy in children with acute lymphoblastic leukemia (L-2 protocol)

1974 • 85 citations

Acute Myelocytic Leukemia

1976 • 79 citations

Cytarabine for acute leukemia in adults. Effect of schedule on therapeutic response

1974 • 77 citations

Progress in the Treatment of Adults With Acute Leukemia

1976 • 64 citations

Treatment of Acute Myeloid Leukaemia with Daunorubicin, Cytosine Arabinoside, Mercaptopurine, L‐Asparaginase, Prednisone and Thioguanine: Results of Treatment with Five Multiple‐Drug Schedules

1974 • 60 citations

Cytarabine for Acute Leukemia in Adults

1974 • 44 citations

Adriamycin-cytosine arabinoside therapy for adult acute myelocytic leukemia.

1977 • 38 citations

Randomized clinical trial of cystosine arabinoside and 6-thioguanine in remission induction and consolidation of adult nonlymphocytic acute leukemia

1977 • 29 citations

Combination Chemotherapy of Adult Acute Nonlymphoblastic Leukemia

1972 • 29 citations

Early deaths in acute myelogenous leukemia

1977 • 21 citations

Development of a combination chemotherapy program for adult acute leukemia: CAM and CAM-L

1973 • 20 citations

A second comparative trial of remission induction (by cytosine arabinoside given every 12 hours, or C.A.R. and thioguanine, or C.A.R. and daunorubicine) and maintenance therapy (by C.A.R. or methylgag) in acute myeloid leukaemia

1974 • 17 citations